Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
3,381
-3
-0.1% -$1.03K 0.26% 68
2026
Q1
$1.19M Sell
3,384
-53
-2% -$18.9K 0.31% 70
2025
Q4
$1.12M Sell
3,437
-150
-4% -$47.6K 0.28% 72
2025
Q3
$1.01M Sell
3,587
-42
-1% -$12.2K 0.26% 74
2025
Q2
$1.01M Buy
3,629
+28
+0.8% +$7.93K 0.28% 73
2025
Q1
$1.12M Sell
3,601
-2
-0.1% -$591 0.36% 71
2024
Q4
$939K Buy
3,603
+4
+0.1% +$1.19K 0.28% 74
2024
Q3
$1.16M Sell
3,599
-25
-0.7% -$8.18K 0.36% 72
2024
Q2
$1.13M Buy
3,624
+25
+0.7% +$7.34K 0.36% 71
2024
Q1
$1.02M Sell
3,599
-23
-0.6% -$6.73K 0.35% 71
2023
Q4
$1.04M Sell
3,622
-20
-0.5% -$5.45K 0.39% 72
2023
Q3
$979K Sell
3,642
-3
-0.1% -$749 0.41% 73
2023
Q2
$809K Sell
3,645
-13
-0.4% -$3.02K 0.32% 86
2023
Q1
$884K Buy
3,658
+12
+0.3% +$2.95K 0.38% 86
2022
Q4
$958K Sell
3,646
-8
-0.2% -$2.14K 0.43% 79
2022
Q3
$824K Buy
3,654
+17
+0.5% +$4.12K 0.4% 83
2022
Q2
$885K Sell
3,637
-40
-1% -$9.8K 0.4% 87
2022
Q1
$889K Sell
3,677
-49
-1% -$11.3K 0.34% 88
2021
Q4
$838K Buy
+3,726
New +$786K 0.3% 90
2019
Q2
Sell
-14,848
Closed -$2.82M 75
2019
Q1
$2.82M Sell
14,848
-36
-0.2% -$6.88K 1.48% 24
2018
Q4
$2.9M Sell
14,884
-365
-2% -$71.2K 1.77% 21
2018
Q3
$3.16M Sell
15,249
-4
-0% -$788 1.56% 27
2018
Q2
$2.82M Buy
15,253
+82
+0.5% +$14.5K 1.51% 32
2018
Q1
$2.59M Sell
15,171
-376
-2% -$69K 1.46% 32
2017
Q4
$2.7M Sell
15,547
-79
-0.5% -$14K 1.45% 33
2017
Q3
$2.91M Sell
15,626
-312
-2% -$55.3K 1.68% 30
2017
Q2
$2.75M Sell
15,938
-314
-2% -$51.1K 1.66% 25
2017
Q1
$2.67M Sell
16,252
-16
-0.1% -$2.66K 1.63% 23
2016
Q4
$2.38M Sell
16,268
-60
-0.4% -$9.03K 1.53% 34
2016
Q3
$2.72M Buy
16,328
+90
+0.6% +$15.2K 1.72% 26
2016
Q2
$2.47M Buy
16,238
+70
+0.4% +$10.9K 1.66% 30
2016
Q1
$2.42M Buy
+16,168
New +$2.4M 1.62% 31
2015
Q4
Sell
-1,615
Closed -$223K 69
2015
Q3
$223K Buy
+1,615
New +$255K 0.17% 57

Other funds holding AMGN

Scott & Selber Inc's AMGN Position: Q2 2026 in Review

Scott & Selber Inc reduced its Amgen (AMGN) stake by 0.09% in Q2 2026, selling an estimated $1.03K and leaving 3,381 shares worth $1.22M. The position accounts for 0.26% of the portfolio, ranked #68.

Scott & Selber Inc first reported a position in AMGN in Q3 2015 and has held it in 33 quarters since. The position peaked at $3.16M in Q3 2018. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Scott & Selber Inc held 3,381 shares of Amgen worth $1.22M as of Q2 2026.
  • Scott & Selber Inc sold 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.26% of Scott & Selber Inc's portfolio in Q2 2026, its #68 holding.
  • Scott & Selber Inc first reported a position in Amgen in Q3 2015 and has held it in 33 quarters since.
  • Scott & Selber Inc's Amgen position peaked at $3.16M in Q3 2018.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Scott & Selber Inc's 13F filing for Q2 2026, filed 8 Jul 2026.